Report Detail

Other Global Colorectal Cancer Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4594472
  • |
  • 12 June, 2024
  • |
  • Global
  • |
  • 123 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

According to our (Global Info Research) latest study, the global Colorectal Cancer Therapeutics market size was valued at USD 12490 million in 2023 and is forecast to a readjusted size of USD 17250 million by 2030 with a CAGR of 4.7% during review period.
Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). A cancer is the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Colorectal Cancer Therapeutics industry chain, the market status of Hospitals (Diagnostics, Therapeutics), Clinic (Diagnostics, Therapeutics), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Colorectal Cancer Therapeutics.
Regionally, the report analyzes the Colorectal Cancer Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Colorectal Cancer Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Colorectal Cancer Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Colorectal Cancer Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Diagnostics, Therapeutics).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Colorectal Cancer Therapeutics market.
Regional Analysis: The report involves examining the Colorectal Cancer Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Colorectal Cancer Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Colorectal Cancer Therapeutics:
Company Analysis: Report covers individual Colorectal Cancer Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Colorectal Cancer Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinic).
Technology Analysis: Report covers specific technologies relevant to Colorectal Cancer Therapeutics. It assesses the current state, advancements, and potential future developments in Colorectal Cancer Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Colorectal Cancer Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Colorectal Cancer Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Diagnostics
Therapeutics
Market segment by Application
Hospitals
Clinic
Research Institutions
Market segment by players, this report covers
Taiho Pharma
Merck KGaA
Amgen
Takeda
Roche
Eli Lilly
Sanofi
Regeneron
Bayer
Onyx
Bristol-Myers Squib
Sumitomo Dainippon Pharma
Array BioPharma
Hutchison MediPharma
Jiangsu Hengrui Medicine
Jiangsu Chia-Tai Tianqing
Suzhou Zelgen Biopharmaceuticals
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Colorectal Cancer Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Colorectal Cancer Therapeutics, with revenue, gross margin and global market share of Colorectal Cancer Therapeutics from 2019 to 2024.
Chapter 3, the Colorectal Cancer Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Colorectal Cancer Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Colorectal Cancer Therapeutics.
Chapter 13, to describe Colorectal Cancer Therapeutics research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Colorectal Cancer Therapeutics
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Colorectal Cancer Therapeutics by Type
    • 1.3.1 Overview: Global Colorectal Cancer Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Colorectal Cancer Therapeutics Consumption Value Market Share by Type in 2023
    • 1.3.3 Diagnostics
    • 1.3.4 Therapeutics
  • 1.4 Global Colorectal Cancer Therapeutics Market by Application
    • 1.4.1 Overview: Global Colorectal Cancer Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Clinic
    • 1.4.4 Research Institutions
  • 1.5 Global Colorectal Cancer Therapeutics Market Size & Forecast
  • 1.6 Global Colorectal Cancer Therapeutics Market Size and Forecast by Region
    • 1.6.1 Global Colorectal Cancer Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Colorectal Cancer Therapeutics Market Size by Region, (2019-2030)
    • 1.6.3 North America Colorectal Cancer Therapeutics Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Colorectal Cancer Therapeutics Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Colorectal Cancer Therapeutics Market Size and Prospect (2019-2030)
    • 1.6.6 South America Colorectal Cancer Therapeutics Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Colorectal Cancer Therapeutics Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Taiho Pharma
    • 2.1.1 Taiho Pharma Details
    • 2.1.2 Taiho Pharma Major Business
    • 2.1.3 Taiho Pharma Colorectal Cancer Therapeutics Product and Solutions
    • 2.1.4 Taiho Pharma Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Taiho Pharma Recent Developments and Future Plans
  • 2.2 Merck KGaA
    • 2.2.1 Merck KGaA Details
    • 2.2.2 Merck KGaA Major Business
    • 2.2.3 Merck KGaA Colorectal Cancer Therapeutics Product and Solutions
    • 2.2.4 Merck KGaA Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Merck KGaA Recent Developments and Future Plans
  • 2.3 Amgen
    • 2.3.1 Amgen Details
    • 2.3.2 Amgen Major Business
    • 2.3.3 Amgen Colorectal Cancer Therapeutics Product and Solutions
    • 2.3.4 Amgen Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Amgen Recent Developments and Future Plans
  • 2.4 Takeda
    • 2.4.1 Takeda Details
    • 2.4.2 Takeda Major Business
    • 2.4.3 Takeda Colorectal Cancer Therapeutics Product and Solutions
    • 2.4.4 Takeda Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Takeda Recent Developments and Future Plans
  • 2.5 Roche
    • 2.5.1 Roche Details
    • 2.5.2 Roche Major Business
    • 2.5.3 Roche Colorectal Cancer Therapeutics Product and Solutions
    • 2.5.4 Roche Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Roche Recent Developments and Future Plans
  • 2.6 Eli Lilly
    • 2.6.1 Eli Lilly Details
    • 2.6.2 Eli Lilly Major Business
    • 2.6.3 Eli Lilly Colorectal Cancer Therapeutics Product and Solutions
    • 2.6.4 Eli Lilly Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Eli Lilly Recent Developments and Future Plans
  • 2.7 Sanofi
    • 2.7.1 Sanofi Details
    • 2.7.2 Sanofi Major Business
    • 2.7.3 Sanofi Colorectal Cancer Therapeutics Product and Solutions
    • 2.7.4 Sanofi Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Sanofi Recent Developments and Future Plans
  • 2.8 Regeneron
    • 2.8.1 Regeneron Details
    • 2.8.2 Regeneron Major Business
    • 2.8.3 Regeneron Colorectal Cancer Therapeutics Product and Solutions
    • 2.8.4 Regeneron Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Regeneron Recent Developments and Future Plans
  • 2.9 Bayer
    • 2.9.1 Bayer Details
    • 2.9.2 Bayer Major Business
    • 2.9.3 Bayer Colorectal Cancer Therapeutics Product and Solutions
    • 2.9.4 Bayer Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Bayer Recent Developments and Future Plans
  • 2.10 Onyx
    • 2.10.1 Onyx Details
    • 2.10.2 Onyx Major Business
    • 2.10.3 Onyx Colorectal Cancer Therapeutics Product and Solutions
    • 2.10.4 Onyx Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Onyx Recent Developments and Future Plans
  • 2.11 Bristol-Myers Squib
    • 2.11.1 Bristol-Myers Squib Details
    • 2.11.2 Bristol-Myers Squib Major Business
    • 2.11.3 Bristol-Myers Squib Colorectal Cancer Therapeutics Product and Solutions
    • 2.11.4 Bristol-Myers Squib Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Bristol-Myers Squib Recent Developments and Future Plans
  • 2.12 Sumitomo Dainippon Pharma
    • 2.12.1 Sumitomo Dainippon Pharma Details
    • 2.12.2 Sumitomo Dainippon Pharma Major Business
    • 2.12.3 Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Product and Solutions
    • 2.12.4 Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Sumitomo Dainippon Pharma Recent Developments and Future Plans
  • 2.13 Array BioPharma
    • 2.13.1 Array BioPharma Details
    • 2.13.2 Array BioPharma Major Business
    • 2.13.3 Array BioPharma Colorectal Cancer Therapeutics Product and Solutions
    • 2.13.4 Array BioPharma Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Array BioPharma Recent Developments and Future Plans
  • 2.14 Hutchison MediPharma
    • 2.14.1 Hutchison MediPharma Details
    • 2.14.2 Hutchison MediPharma Major Business
    • 2.14.3 Hutchison MediPharma Colorectal Cancer Therapeutics Product and Solutions
    • 2.14.4 Hutchison MediPharma Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Hutchison MediPharma Recent Developments and Future Plans
  • 2.15 Jiangsu Hengrui Medicine
    • 2.15.1 Jiangsu Hengrui Medicine Details
    • 2.15.2 Jiangsu Hengrui Medicine Major Business
    • 2.15.3 Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Product and Solutions
    • 2.15.4 Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Jiangsu Hengrui Medicine Recent Developments and Future Plans
  • 2.16 Jiangsu Chia-Tai Tianqing
    • 2.16.1 Jiangsu Chia-Tai Tianqing Details
    • 2.16.2 Jiangsu Chia-Tai Tianqing Major Business
    • 2.16.3 Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Product and Solutions
    • 2.16.4 Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Jiangsu Chia-Tai Tianqing Recent Developments and Future Plans
  • 2.17 Suzhou Zelgen Biopharmaceuticals
    • 2.17.1 Suzhou Zelgen Biopharmaceuticals Details
    • 2.17.2 Suzhou Zelgen Biopharmaceuticals Major Business
    • 2.17.3 Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Product and Solutions
    • 2.17.4 Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.17.5 Suzhou Zelgen Biopharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Colorectal Cancer Therapeutics Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Colorectal Cancer Therapeutics by Company Revenue
    • 3.2.2 Top 3 Colorectal Cancer Therapeutics Players Market Share in 2023
    • 3.2.3 Top 6 Colorectal Cancer Therapeutics Players Market Share in 2023
  • 3.3 Colorectal Cancer Therapeutics Market: Overall Company Footprint Analysis
    • 3.3.1 Colorectal Cancer Therapeutics Market: Region Footprint
    • 3.3.2 Colorectal Cancer Therapeutics Market: Company Product Type Footprint
    • 3.3.3 Colorectal Cancer Therapeutics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Colorectal Cancer Therapeutics Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Colorectal Cancer Therapeutics Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Colorectal Cancer Therapeutics Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Colorectal Cancer Therapeutics Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Colorectal Cancer Therapeutics Consumption Value by Type (2019-2030)
  • 6.2 North America Colorectal Cancer Therapeutics Consumption Value by Application (2019-2030)
  • 6.3 North America Colorectal Cancer Therapeutics Market Size by Country
    • 6.3.1 North America Colorectal Cancer Therapeutics Consumption Value by Country (2019-2030)
    • 6.3.2 United States Colorectal Cancer Therapeutics Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Colorectal Cancer Therapeutics Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Colorectal Cancer Therapeutics Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Colorectal Cancer Therapeutics Consumption Value by Type (2019-2030)
  • 7.2 Europe Colorectal Cancer Therapeutics Consumption Value by Application (2019-2030)
  • 7.3 Europe Colorectal Cancer Therapeutics Market Size by Country
    • 7.3.1 Europe Colorectal Cancer Therapeutics Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Colorectal Cancer Therapeutics Market Size and Forecast (2019-2030)
    • 7.3.3 France Colorectal Cancer Therapeutics Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Colorectal Cancer Therapeutics Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Colorectal Cancer Therapeutics Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Colorectal Cancer Therapeutics Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Colorectal Cancer Therapeutics Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Colorectal Cancer Therapeutics Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Colorectal Cancer Therapeutics Market Size by Region
    • 8.3.1 Asia-Pacific Colorectal Cancer Therapeutics Consumption Value by Region (2019-2030)
    • 8.3.2 China Colorectal Cancer Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Colorectal Cancer Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Colorectal Cancer Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.5 India Colorectal Cancer Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Colorectal Cancer Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Colorectal Cancer Therapeutics Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Colorectal Cancer Therapeutics Consumption Value by Type (2019-2030)
  • 9.2 South America Colorectal Cancer Therapeutics Consumption Value by Application (2019-2030)
  • 9.3 South America Colorectal Cancer Therapeutics Market Size by Country
    • 9.3.1 South America Colorectal Cancer Therapeutics Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Colorectal Cancer Therapeutics Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Colorectal Cancer Therapeutics Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Colorectal Cancer Therapeutics Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Colorectal Cancer Therapeutics Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Colorectal Cancer Therapeutics Market Size by Country
    • 10.3.1 Middle East & Africa Colorectal Cancer Therapeutics Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Colorectal Cancer Therapeutics Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Colorectal Cancer Therapeutics Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Colorectal Cancer Therapeutics Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Colorectal Cancer Therapeutics Market Drivers
  • 11.2 Colorectal Cancer Therapeutics Market Restraints
  • 11.3 Colorectal Cancer Therapeutics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Colorectal Cancer Therapeutics Industry Chain
  • 12.2 Colorectal Cancer Therapeutics Upstream Analysis
  • 12.3 Colorectal Cancer Therapeutics Midstream Analysis
  • 12.4 Colorectal Cancer Therapeutics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Colorectal Cancer Therapeutics. Industry analysis & Market Report on Colorectal Cancer Therapeutics is a syndicated market report, published as Global Colorectal Cancer Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Colorectal Cancer Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,683.08
    4,024.62
    5,366.16
    3,194.64
    4,791.96
    6,389.28
    551,197.20
    826,795.80
    1,102,394.40
    290,719.20
    436,078.80
    581,438.40
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report